InChI=1S/C21H41N5O11/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31/h5-21,26-32H,2-4,22-25H2,1H3/t5-,6+,7-,8+,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20-,21-/m1/s1 |
XZNUGFQTQHRASN-XQENGBIVSA-N |
[H][C@]12C[C@@H](N)[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)O[C@]1([H])[C@H](O)[C@H](NC)[C@@H](O[C@H]1O[C@H](CO)[C@@H](N)[C@H](O)[C@H]1O)O2 |
|
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
antibacterial drug
A drug used to treat or prevent bacterial infections.
|
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
|
|
View more via ChEBI Ontology
(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl 4-amino-4-deoxy-α-D-glucopyranoside
|
apramicina
|
ChemIDplus
|
apramycin
|
ChemIDplus
|
apramycine
|
ChemIDplus
|
apramycinum
|
ChemIDplus
|
4-O-((8R)-2-amino-8-O-(4-amino-4-deoxy-α-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-α-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-D-streptamine
|
ChemIDplus
|
4-O-(3α-amino-6α-((4-amino-4-deoxy-α-D-glucopyranosyl)oxy)-2,3,4,5aβ,6,7,8,8aα-octahydro-8β-hydroxy-7β-(methylamino)pyrano(3,2-b)pyran-2α-yl)-2-deoxy-D-streptamine
|
ChemIDplus
|
APRAMYCIN
|
PDBeChem
|
Apramycin
|
KEGG COMPOUND
|
nebramycin factor 2
|
ChemIDplus
|
nebramycin II
|
ChemIDplus
|
1743
|
VSDB
|
AM2
|
PDBeChem
|
C01555
|
KEGG COMPOUND
|
D02322
|
KEGG DRUG
|
DB04626
|
DrugBank
|
US3691279
|
Patent
|
View more database links |
37321-09-8
|
CAS Registry Number
|
KEGG COMPOUND
|
37321-09-8
|
CAS Registry Number
|
ChemIDplus
|
4610404
|
Reaxys Registry Number
|
Reaxys
|
1249675
|
PubMed citation
|
Europe PMC
|
340441
|
PubMed citation
|
Europe PMC
|
690031
|
PubMed citation
|
Europe PMC
|
932851
|
PubMed citation
|
Europe PMC
|
|